Fortive Corporation FTV

NYSE · Technology · Hardware, Equipment & Parts

$64.16

Close on Fri, 20 Nov 2026 · market value $19.1B

What the price is betting on

In line with its record

At $64, the price assumes revenue grows about 5% a year for five years, from $4.4B to about $5.4B by FY2030. That is about one and a half times what analysts expect for the next two years and well above the company's own last three years.

The price assumes5%
Analysts, next two years3.8%
Last 3 years−11%

Revenue growth a year. The price figure comes from a reverse DCF at a 9% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than FTV? Check up to 5 of your stocks at once, free, no account.

0$2B$4B$6B$8B$4.4B'22'23'24'25Oct '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$53

Base

$60

Bull

$66

Today $64

  • Bear $53. Sales grow 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $60. Sales grow 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $66. Sales grow 6% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$4.4B$4.4B, on the path
  3. FY2027$4.7B$4.6B, on the path
  4. FY2028$4.9B$4.8B, on the path
  5. FY2029$5.2B$4.9B, below the path
  6. FY2030$5.4B$5.1B, below the path

Each year's revenue at 5% growth from $4.4B in the 12 months to October 2026.

At a glance

Technology · Hardware, Equipment & Parts · listed on NYSE

Revenue, FY2025
$5.1B
Growth, 3 years a year
−11%
Cash margin
19%
Net debt
$2.8B
Shares, 3-year change
−11%
Dividend yield
0.5%

What other technology prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.